The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application, identified as TM99492396, for the mark 'AUBRA AX'. The application specifies its intended use in the field of oral contraceptives and was filed on November 12, 2025. This filing indicates a potential future market entry for a new pharmaceutical product.

While this is a trademark filing and not a regulatory approval for the product itself, companies in the pharmaceutical sector should be aware of new brand names entering the trademark application process. This filing does not impose any immediate compliance obligations but serves as an indicator of potential future product launches and market activity. No specific actions are required by compliance officers at this stage.